Literature DB >> 26297936

Chronic pain in Noonan Syndrome: A previously unreported but common symptom.

Sravanthi Vegunta1, Richard Cotugno2, Amber Williamson2, Theresa A Grebe3.   

Abstract

Noonan syndrome (NS) is a multiple malformation syndrome characterized by pulmonic stenosis, cardiomyopathy, short stature, lymphatic dysplasia, craniofacial anomalies, cryptorchidism, clotting disorders, and learning disabilities. Eight genes in the RAS/MAPK signaling pathway are implicated in NS. Chronic pain is an uncommon feature. To investigate the prevalence of pain in NS, we distributed a two-part questionnaire about pain among NS individuals at the Third International Meeting on Genetic Syndromes of the Ras/MAPK Pathway. The first part of the questionnaire queried demographic information among all NS participants. The second part was completed by individuals with chronic pain. Questions included musculoskeletal problems and clinical features of pain. Forty-five questionnaires were analyzed; 53% of subjects were female. Mean age was 17 (2-48) years; 47% had a PTPN11 mutation. Sixty-two percent (28/45) of individuals with NS experienced chronic pain. There was a significant relationship between prevalence of pain and residing in a cold climate (P = 0.004). Pain occurred commonly in extremities/joints and head/trunk, but more commonly in extremities/joints (P = 0.066). Subjects with hypermobile joints were more likely to have pain (P = 0.052). Human growth hormone treatment was not statistically significant among subjects without chronic pain (P = 0.607). We conclude that pain is a frequent and under-recognized clinical feature of NS. Chronic pain may be associated with joint hypermobility and aggravated by colder climate. Our study is a preliminary investigation that should raise awareness about pain as a common symptom in children and adults with NS.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  Noonan syndrome; Ras-dependent mitogen-activated protein kinase kinase kinase; chronic pain; climate; genotype-phenotype correlations; growth hormone; joint hypermobility; medical genetics

Mesh:

Substances:

Year:  2015        PMID: 26297936     DOI: 10.1002/ajmg.a.37337

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  3 in total

1.  Adult spinal cord neurogenesis: A regulator of nociception.

Authors:  Gabriel Rusanescu
Journal:  Neurogenesis (Austin)       Date:  2016-11-14

Review 2.  RAS and downstream RAF-MEK and PI3K-AKT signaling in neuronal development, function and dysfunction.

Authors:  Jian Zhong
Journal:  Biol Chem       Date:  2016-03       Impact factor: 3.915

3.  Pain reporting and analgesia management in 270 children with a progressive neurologic, metabolic or chromosomally based condition with impairment of the central nervous system: cross-sectional, baseline results from an observational, longitudinal study.

Authors:  Stefan J Friedrichsdorf; Andrea C Postier; Gail S Andrews; Karen Es Hamre; Rose Steele; Harold Siden
Journal:  J Pain Res       Date:  2017-07-31       Impact factor: 3.133

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.